China Factory Peptide Synthesis Vials Lyophilized Peptides Powder Retatrutide 5mg+cagrilintide 5mg RC10
TDS
898757-96-5
Pharmaceutical Grade
99%
shanghai
JL
10ml
Yes
2027-12-08
Peptide
-
Product Description
-
Seller Information
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
Methanone, (3,4-dimethylphenyl)[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylmethyl)phenyl]-
Other Name:Methanone,(3,4-dimethylphenyl)[4-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylmethyl)phenyl]-
CAS No.:898757-96-5
Molecular Formula:C23H27NO3
InChIKeys:InChIKey=YCBQLPPQIKUZLF-UHFFFAOYSA-N
Molecular Weight:365.46500
Exact Mass:365.47
DSSTox ID:DTXSID60642864
Categories:
Characteristics-
PSA:
38.77000
XLogP3:3.81120
Density:1.19g/cm3
Boiling Point:533.7ºC at 760 mmHg
Flash Point:276.6ºC
Refractive Index:1.606
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide
-
Location:
zhejiangshengjinhuashiyiwushijiangdongjiedaodongnanlu656hao
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Liraglutide LL5 LL10 LL30 Factory direct delivery price advantage and quality advantage
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
BBG70 GLOW70 Peptide 99% Purity Lyophilized Vial Wholesale Fast Shipping COA Provided
Pharmaceutical Grade / 99%
$6-7/UNIT FOB
-
-
-
-
Pancragen PA20 Factory direct delivery price advantage and quality advantage
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
MT-1 API Raw Material Powder | High Purity MT-1 Supplier & Manufacturer
Pharmaceutical Grade / 99%
$33-36/UNIT FOB
-
-
-
-
Cortagen COR20 Factory direct delivery price advantage and quality advantage
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
5-amino-1mq API Raw Material Powder | High Purity 5-amino-1mq Supplier & Manufacturer
Pharmaceutical Grade / 99%
$33-36/UNIT FOB
-